These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 18782999)

  • 1. IV iron therapy and anemia management in patients on hemodialysis: benefits of a revised CQI strategy.
    Bowe D
    Nephrol Nurs J; 2008; 35(4):371-7, 394; quiz 378-9. PubMed ID: 18782999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving IV iron and anemia management in the hemodialysis setting: a collaborative CQI approach.
    Pruett B; Johnson S; O'Keefe N
    Nephrol Nurs J; 2007; 34(2):206-13. PubMed ID: 17486951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Updating practices in an evolving IV iron and anemia environment: practical solutions.
    Amerling R; Easom A; Juergensen P
    Nephrol Nurs J; 2007; 34(5):533-41; quiz 542-3. PubMed ID: 18041456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IV iron use in patients with higher serum ferritin: case study on anemia in kidney disease.
    Larson K
    Nephrol Nurs J; 2008; 35(2):184-93; quiz 194-5. PubMed ID: 18472686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maintaining higher TSATs and other iron indices is beneficial in management of anemic hemodialysis patients.
    Besarab A; Dalton CL
    Nephrol Nurs J; 2001 Aug; 28(4):429-34. PubMed ID: 12143465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjusting i.v. iron and EPO doses in patients on hemodialysis prior to continuing surgery: can we protect our patients education from iron-deficiency anemia?
    Deaver K; Bennington L
    Nephrol Nurs J; 2006; 33(4):430-7; quiz 438. PubMed ID: 17002001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stabilizing hemoglobin levels: what's new in IV iron and anemia management?
    Fishbane S; Larson K; VanBuskirk S
    Nephrol Nurs J; 2008; 35(5):493-502. PubMed ID: 18856080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemoglobin control, ESA resistance, and regular low-dose IV iron therapy: a review of the evidence.
    Singh A
    Semin Dial; 2009; 22(1):64-9. PubMed ID: 19175537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The challenges of using serum ferritin to guide i.v. iron treatment practices in patients on hemodialysis with anemia.
    Easom A
    Nephrol Nurs J; 2006; 33(5):543-51; quiz 552-3. PubMed ID: 17044438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementing an i.v. iron maintenance regimen protocol in a hemodialysis practice.
    Gilmartin C; Na-Thalang K; Arruda J; Lau A
    Nephrol Nurs J; 2004; 31(6):663-71. PubMed ID: 15686330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive vision for intravenous iron therapy.
    Coyne DW
    Am J Kidney Dis; 2008 Dec; 52(6 Suppl):S14-20. PubMed ID: 19010257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron replacement and supplementation in patients with chronic kidney disease.
    Wazny LD; Raymond CB
    CANNT J; 2011; 21(4):26-30; quiz 31-2. PubMed ID: 22324122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The safety of intravenous iron dextran (Dexferrum) during hemodialysis in patients with end stage renal disease.
    Hood SA; O'Brien M; Higgins R
    Nephrol Nurs J; 2000 Feb; 27(1):41-2. PubMed ID: 10852689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correction of anemia in hemodialysis, effect of intravenous iron without erythropoietin].
    Alvo M; Elgueta L; Aragón H; Cotera A
    Rev Med Chil; 2002 Aug; 130(8):865-8. PubMed ID: 12360794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upper limit of serum ferritin: misinterpretation of the 2006 KDOQI anemia guidelines.
    Fishbane S
    Semin Dial; 2008; 21(3):217-20. PubMed ID: 18248518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness of low-dose maintenance i.v. iron therapy: a dialysis facility's experience.
    Peter J; Finkelstein F
    Nephrol Nurs J; 2006; 33(1):71-4, 90. PubMed ID: 16538930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Achieving optimal patient outcomes with intravenous iron.
    Colfer M
    Nephrol Nurs J; 2003 Aug; 30(4):449-53; quiz 454-5. PubMed ID: 14533524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving the management of anemia in hemodialysis patients by implementing the continuous quality improvement program.
    Chen M; Deng JH; Zhou FD; Wang M; Wang HY
    Blood Purif; 2006; 24(3):282-6. PubMed ID: 16462138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The benefits of IV iron therapy in treating anemia in patients with renal disease and comorbid cardiovascular disease.
    Singh AK; Hertello P
    Nephrol Nurs J; 2005; 32(2):199-206; quiz 207-8. PubMed ID: 15889804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum ferritin in chronic kidney disease: reconsidering the upper limit for iron treatment.
    Fishbane S; Kalantar-Zadeh K; Nissenson AR
    Semin Dial; 2004; 17(5):336-41. PubMed ID: 15461737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.